Bilateral EK Rejection After COVID-19 Vaccine

Eye Contact Lens. 2021 Nov 1;47(11):625-628. doi: 10.1097/ICL.0000000000000840.

Abstract

Owing to its rapid development, short-term and long-term effects of the COVID-19 vaccine are still not well understood. This case report highlights bilateral corneal endothelial graft rejection after administration of the Pfizer COVID-19 vaccine. A 73-year-old woman with bilateral Descemet stripping endothelial keratoplasty presented with bilateral decreased visual acuity, ocular pain, and photophobia after her second dose of the Pfizer-BioNTech COVID-19 vaccine. Two weeks after vaccine administration, the uncorrected visual acuity was 20/70 and 20/40. Central corneal thickness as measured by ultrasound was 809 and 825 μm and by Scheimfplug imaging was 788 and 751 μm at the pupil center. Slit-lamp biomicroscopy revealed quiet conjunctiva and sclera but was significant for thickened corneas with Descemet folds in both eyes. The patient was instructed to use prednisolone acetate 1% every 1 to 2 hours with Muro ointment at bedtime.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • COVID-19 Vaccines
  • COVID-19*
  • Corneal Diseases* / surgery
  • Descemet Membrane
  • Descemet Stripping Endothelial Keratoplasty*
  • Endothelium, Corneal
  • Female
  • Graft Rejection / prevention & control
  • Humans
  • Retrospective Studies
  • SARS-CoV-2

Substances

  • COVID-19 Vaccines